SIGNAL GRIDv0.1

Exclusive | Lilly Agrees to Buys Trio of Vaccine Developers - WSJ

1 sources4 storiesFirst seen 5/26/2026Score49Mixed Progress
Single Source
CoverageRecencyEngagementVelocityBignessConfidenceClipability
Bigness
49
Coverage
13
Recency
98
Engagement
21
Velocity
100
Confidence
49
Clipability
60
Polarization
0
Claims
6
Contradictions
0
Breakthrough
50

Sentiment Mix

Positive0%
Neutral100%
Negative0%

Geography

North America

Expert Signals

Politics - Google News US Headlines

source4 mentions

AI-Generated Claims

Generated from linked receipts; click sources for full context.

Lilly announces three acquisitions to build infectious disease portfolio - PR Newswire.

Supported by 1 story

Lilly announces three acquisitions to build infectious disease portfolio PR NewswireLilly Agrees to Buy Trio of Vaccine Developers WSJEli Lilly Will Buy Three Vaccine Developers

Supported by 1 story

Lilly announces three acquisitions to build infectious disease portfolio

Supported by 1 story

Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals

Supported by 1 story

Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals CNBCExclusive

Supported by 1 story

Exclusive | Lilly Agrees to Buys Trio of Vaccine Developers WSJEli Lilly to buy three small vaccine developers statnews.comLilly to acquire three vaccine developers for nearly $4 billion Yahoo FinanceLilly to Buy Three Vaccine Developers for Up to $3.8 Billion Bloomberg.comEli Lilly acquires three vaccine developers for $3.8 billion qz.com

Supported by 1 story

Related Events

Timeline (4 stories)

Receipts (4)

Bias Snapshot

Center
Left 0%Center 100%Right 0%
Blognews.google.com5/26/2026
Blognews.google.com5/26/2026
Blognews.google.com5/26/2026
Blognews.google.com5/26/2026